Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 23, 2015 12:43 AM ET

Biotechnology

Company Overview of Vanda Pharmaceuticals, Inc.

Executive Profile

H. Thomas Watkins

Chairman, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee, Vanda Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 5 different industries.

See Board Relationships
61$150,401

Background

Mr. H. Thomas Watkins, also known as Tom served as the Chief Executive Officer and President of Human Genome Sciences Inc., from November 22, 2004 to August 2012. Mr. Watkins has over 20 years of experience at Abbott Laboratories and its affiliates in the U.S. and Asia. He served as the President of TAP Pharmaceutical Products Inc. from September 1998 to August 2004, which is jointly owned by Abbott Laboratories and Takeda Pharmaceutical Company Limited. He joined Abbott ...

Corporate Headquarters

2200 Pennsylvania Avenue NW
Washington, District Of Columbia 20037

United States

Phone: 202-734-3400
Fax: 202-296-1450

Board Members Memberships

Chairman
Director
2004-2012
Former Chief Executive Officer, President and Director
2006-Present
Chairman, Chairman of Nominating/Corporate Governance Committee and Member of Compensation Committee
2014-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Transaction Committee

Education

Bachelor's Degree
College of William & Mary
MBA
The University of Chicago Booth School of Business

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$113,749
Unexercisable Options$6,251
Total Number of Options$120,000

Total Compensation

Total Annual Cash Compensation$60,401
Total Calculated Compensation$150,401
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
$3.1M
Olivier Brandicourt Chief Executive Officer and Director
Sanofi
--
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
$814.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vanda Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.